Kunnumakkara, Ajaikumar B <br/><br/>
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.  [electronic resource] 

 -  Cancer research  Apr 2007 
 - 3853-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-06-4257  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Cell Growth Processes--drug effects<br/>Cell Line, Tumor<br/>Curcumin--administration & dosage<br/>Cyclooxygenase 2--biosynthesis<br/>Deoxycytidine--administration & dosage<br/>Down-Regulation--drug effects<br/>Drug Synergism<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Male<br/>Matrix Metalloproteinase 9--biosynthesis<br/>Mice<br/>NF-kappa B--antagonists & inhibitors<br/>Neovascularization, Pathologic--drug therapy<br/>Pancreatic Neoplasms--blood supply<br/>Vascular Endothelial Growth Factor A--biosynthesis<br/>Xenograft Model Antitumor Assays<br/>Gemcitabine